Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SHR-1139 for efficacy, safety, and pharmacokinetics in adults with moderately to severely active ulcerative colitis; recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SHR-1139

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Adult Patients With Moderately to Severely Active Ulcerative Colitis | Phase 2 | Status: RECRUITING